Press Release CentralSquare’s AI Helps Investigators Solve 33-Year-Old Illinois Cold Case 10 July 2026
Press Release KBRA Affirms SmartStop OP, L.P. BBB Issuer and Senior Note Ratings; Stable Outlook 10 July 2026
Press Release Barings Global Short Duration High Yield Fund Announces July 2026 Monthly Distribution of $0.1223 per Share 10 July 2026
Press Release Nearly 100 Acquisitions, One Source of Truth: How Vensure Executes Faster With ZoomInfo 10 July 2026
Press Release Glancy Prongay Wolke & Rotter LLP Announces Investigation of The GEO Group, Inc. (GEO) on Behalf of Investors 10 July 2026
Press Release Glancy Prongay Wolke & Rotter LLP Announces Investigation of The GEO Group, Inc. (GEO) on Behalf of Investors 10 July 2026
Press Release FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC) 10 July 2026
Press Release FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC) 10 July 2026
